AHA: American Heart Association
Conference Coverage
ISCHEMIA-CKD: No benefit for coronary revascularization in advanced CKD with stable angina
PHILADELPHIA – At 3 years, more than 27% of patients were dead regardless of the coronary artery disease management strategy.
Conference Coverage
RNA inhibitors silence two new targets in dyslipidemia
PHILADELPHIA –
Conference Coverage
The TWILIGHT of aspirin post-PCI for ACS?
PHILADELPHIA –
Conference Coverage
GALILEO, GALILEO 4D: Mixed results in post-TAVR anticoagulation
Conference Coverage
ISCHEMIA trial hailed as practice changing
PHILADELPHIA – The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
Conference Coverage
Weaknesses exposed in valsartan recall
PHILADELPHIA – A population study in Canada exposed incomplete adherence after the valsartan recall of July 2018.
Conference Coverage
Stress echo could predict PCI efficacy in stable CAD
Conference Coverage
Getting high heightens stroke, arrhythmia risks
Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies.
Conference Coverage
Biomarkers predict VTE risk with menopausal oral hormone therapy
CHICAGO – Pretreatment high D-dimer spells 500% increased VTE risk on oral hormone therapy.
Conference Coverage
PCSK9 inhibition isn’t the answer for high Lp(a)
CHICAGO – “The reality is that for now we don’t have any drugs to significantly lower elevated Lp(a),” said Dr. Erik S. Stroes.
Conference Coverage
Subclinical hypothyroidism boosts immediate risk of heart failure
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.
Conference Coverage
Ezetimibe found effective for primary prevention in elderly
CHICAGO – Japanese EWTOPIA 75 study provides first RCT evidence of benefit for LDL-lowering in seniors.
Conference Coverage
Obesity paradox applies to post-stroke mortality
Conference Coverage
Novel agent cut LDL in statin-intolerant patients
CHICAGO – Bempedoic acid will also be tested in combination with ezetimibe in a single pill.